Skip to main content
OpenTrials

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

698 public trials 151 recruiting studies
Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer

NCT00272649

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • UCLA Kidney Cancer Program Los Angeles, California, United States
  • Univ. of Colorado Health Science Center - Division of Medical Oncology Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • The Indiana University Cancer Center/IUPUI Indianapolis, Indiana, United States
View Trial Details
Completed

RNA-Loaded Dendritic Cell Cancer Vaccine

NCT00087984

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of California - Irvine Orange, California, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details
Completed

Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain

NCT00301847

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +25 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • Evanston Northwestern Health Care - Evanston Hospital Evanston, Illinois, United States
  • Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

NCT00003968

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Hunterdon Regional Cancer Center Flemington, New Jersey, United States
  • Kimball Medical Center Lakewood, New Jersey, United States
  • South Jersey Hospital - Millville Millville, New Jersey, United States
  • Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly, New Jersey, United States
View all 17 locations
View Trial Details
Completed

RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib

NCT00410124

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Novartis Investigative Site Fayetteville, Arkansas, United States
  • Novartis Investigative Site Duarte, California, United States
  • Novartis Investigative Site Sacramento, California, United States
  • Novartis Investigative Site San Francisco, California, United States
View all 93 locations
View Trial Details

Related conditions